Literature DB >> 1333489

Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus.

H T Cuypers1, D Bresters, I N Winkel, H W Reesink, A J Weiner, M Houghton, C L van der Poel, P N Lelie.   

Abstract

We have noticed that suboptimal specimen processing and storage conditions may cause false-negative results in the detection of hepatitis C virus (HCV) RNA in plasma or serum. To establish the influence of specimen handling in a serological laboratory on the rate of detection of HCV RNA by the cDNA polymerase chain reaction (cDNA-PCR), we tested routine serum samples and fresh-frozen plasma samples from the same bleeding from confirmed anti-HCV-positive blood donors. When primers from the NS3/NS4 region were used, HCV RNA was detected in fresh-frozen plasma from 67% of the donors, whereas positive results were obtained with only 50% of the serum samples that had been subjected to routine serological procedures. Analysis of the same samples with primers from the highly conserved 5'-terminal region (5'-TR) revealed an HCV RNA detection rate of 92% for both the routine and the fresh-frozen samples. However, the yield of the amplification product in routine samples was strongly reduced compared with that in fresh-frozen plasma. Comparison of both primer sets for cDNA-PCR showed that the 5'-TR primer set was 10- to 100-fold more effective in detecting HCV RNA. We also analyzed the effect of storage of whole EDTA-blood and serum at room temperature and at 4 degrees C on the yield of the amplification product. A rapid decline in detectable HCV RNA of 3 to 4 log units was observed within 14 days when whole blood and serum were stored at room temperature. By contrast, no perceptible reduction in the cDNA-PCR signal was found in freshly prepared serum stored at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333489      PMCID: PMC270636          DOI: 10.1128/jcm.30.12.3220-3224.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus.

Authors:  J T Wang; T H Wang; J C Sheu; S M Lin; J T Lin; D S Chen
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

Authors:  P Farci; H J Alter; D Wong; R H Miller; J W Shih; B Jett; R H Purcell
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

3.  Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.

Authors:  T L Fong; M Shindo; S M Feinstone; J H Hoofnagle; A M Di Bisceglie
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 4.  Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.

Authors:  M Houghton; A Weiner; J Han; G Kuo; Q L Choo
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

5.  Analysis of genomic variability of hepatitis C virus.

Authors:  H T Cuypers; I N Winkel; C L van der Poel; H W Reesink; P N Lelie; M Houghton; A Weiner
Journal:  J Hepatol       Date:  1991       Impact factor: 25.083

6.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Risk factors in hepatitis C virus-infected blood donors.

Authors:  C van der Poel; H Cuypers; H Reesink; Q L Choo; G Kuo; J Han; S Quan; A Polito; J Verstraten; J van de Wouw
Journal:  Transfusion       Date:  1991-10       Impact factor: 3.157

8.  Impact of specimen handling and storage on detection of hepatitis C virus RNA.

Authors:  M P Busch; J C Wilber; P Johnson; L Tobler; C S Evans
Journal:  Transfusion       Date:  1992-06       Impact factor: 3.157

9.  Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients.

Authors:  D Bresters; E P Mauser-Bunschoten; H T Cuypers; P N Lelie; J H Han; P L Jansen; M Houghton; H W Reesink
Journal:  Scand J Gastroenterol       Date:  1992       Impact factor: 2.423

10.  Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.

Authors:  J A Garson; P W Tuke; M Makris; M Briggs; S J Machin; F E Preston; R S Tedder
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

View more
  18 in total

1.  Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR.

Authors:  Keith R Jerome; Meei-Li Huang; Anna Wald; Stacy Selke; Lawrence Corey
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples.

Authors:  H H Kessler; E Stelzl; R B Raggam; J Haas; F Kirchmeir; K Hegenbarth; E Daghofer; B I Santner; E Marth; R E Stauber
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Assessment of hepatitis B virus DNA stability in serum by the Chiron Quantiplex branched-DNA assay.

Authors:  M Krajden; L Comanor; O Rifkin; A Grigoriew; J M Minor; G F Kapke
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Stability of hepatitis C virus RNA in blood samples by TaqMan real-time PCR.

Authors:  Kenan Sener; Mehmet Yapar; Orhan Bedir; Cem Gül; Omer Coskun; Ayhan Kubar
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

5.  Quantitation of HCV viraemia by branched DNA signal amplification in patients treated with alpha-interferon--a longitudinal study.

Authors:  R Iuliano; A M Pizzigallo; A Alecci; L Barsanti; R Trovato; G Forastieri; S Lico; C Palmieri; M Brizzi; N Marino; L Mecocci; F Mazzotta; L Ceccherini-Nelli
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

6.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  Single-tube single-enzyme reverse transcriptase PCR assay for detection of bovine viral diarrhea virus in pooled bovine serum.

Authors:  D Weinstock; B Bhudevi; A E Castro
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera.

Authors:  M Krajden; J Zhao; C Bourke; V Scalia; P Gill; W Lau
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

9.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

10.  Occult HCV infection: an unexpected finding in a population unselected for hepatic disease.

Authors:  Laura De Marco; Anna Gillio-Tos; Valentina Fiano; Guglielmo Ronco; Vittorio Krogh; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Franco Merletti; Lorenzo Richiardi; Carlotta Sacerdote
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.